Supplementary webappendix
|
|
|
- Jessie Bond
- 6 years ago
- Views:
Transcription
1 Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Elter T, Gercheva-Kyuchukova L, Pylylpenko H, et al. Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. Lancet Oncol 2011; published online Oct 11, DOI: /S (11)70242-X.
2 Web Extra Table 1: AEs Occurring in 5% of Rai Stage I-II Patients (N=102) (N=102) Rai stage I-II patients with at least 1 AE 101 (99 0) (86 3) Pyrexia 64 (62 7) (1 9) Neutropenia 53 (52 0) (47 1) Leukopenia 48 (47 1) (17 6) Chills 33 (32 4) (1 0) Thrombocytopenia 27 (26 5) (20 6) Lymphopenia 24 (23 5) (3 9) Anaemia 23 (22 3) (16 7) Urticaria 16 (15 7) (1 0) CMV test positive 16 (15 7) (1 0) Rash 16 (15 7) (3 9) Infusion-related reaction 15 (14 7) (0 0) Dermatitis allergic 10 (9 8) (2 9) Bronchitis 10 (9 8) (2 9) Cough 10 (9 8) (2 9) Hypertension 10 (9 8) (3 9) Nausea 9 (8 8) (9 8) Diarrhoea 8 (7 8) (4 9) Bronchospasm 8 (7 8) (0 0) Pruritus 7 (6 9) (2 0) Increased ALT 6 (5 9) (3 9) Bone pain 6 (5 9) (0 0) Headache 6 (5 9) (3 9) Pharyngitis 6 (5 9) (2 0) Vomiting 6 (5 9) (2 0) Fatigue 4 (3 9) (5 9) AE, adverse event (regardless of causality, unless otherwise specified); CMV, Cytomegalovirus; ALT, Alanine transaminase Page 1 of 6 Web Extra Material
3 Web Extra Table 2: AEs Occurring in 5% of Rai Stage III-IV Patients (N=60) (N=61) Any grade Maximum Grade Any grade Maximum Grade Rai stage III-IV patients with at least 1 AE 58 (96 7) (96 7) Pyrexia 33 (55 0) (19 7) Neutropenia 32 (53 3) (55 7) Leukopenia 25 (41 7) (11 5) Thrombocytopenia 20 (33 3) (39 3) Chills 16 (26 7) (1 6) Anaemia 12 (20 0) (37 7) Nausea 11 (18 3) (4 9) Lymphopenia 11 (18 3) (4 9) Rash 9 (15 0) (1 6) Vomiting 9 (15 0) (1 6) Headache 8 (13 3) (0 0) Diarrhoea 8 (13 3) (9 8) Infusion-related reaction 8 (13 3) (0 0) Fatigue 7 (11 7) (4 9) Pruritus 7 (11 7) (3 3) Urticaria 7 (11 7) (4 9) Bronchitis 6 (10 0) (3 3) Decreased WBC count 6 (10 0) (3 3) Cytokine release syndrome 5 (8 3) (0 0) Constipation 5 (8 3) (0 0) Insomnia 5 (8 3) (0 0) Pneumonia 5 (8 3) (4 9) Dermatitis allergic 4 (6 7) (0 0) Dyspnoea 4 (6 7) (0 0) Decreased neutrophil count 4 (6 7) (9 8) Decreased platelet count 4 (6 7) (13 1) Bone pain 3 (5 0) (0 0) Cough 3 (5 0) (8 2) CMV test positive 3 (5 0) (0 0) Dizziness 3 (5 0) (3 3) Decreased haemoglobin 3 (5 0) (8 2) Hiccups 3 (5 0) (0 0) Respiratory tract infection 3 (5 0) (4 9) Pollakiuria 3 (5 0) (0 0) Febrile Neutropenia 1 (1 7) (9 8) AE, adverse event (regardless of causality, unless otherwise specified); CMV, Cytomegalovirus; WBC, White blood cell Page 2 of 6 Web Extra Material
4 Web Extra Table 3: AEs Occurring in 5% of Patients 65 years of Age (N=55) (N=59) Patients 65 years old with at least 1 AE 54 (98 2) (94 9) Pyrexia 30 (54 5) (5 1) Neutropenia 28 (50 9) (54 2) Leukopenia 22 (40 0) (22 0) Chills 20 (36 4) (3 4) Thrombocytopenia 17 (30 9) (30 5) Lymphopenia 13 (23 6) (5 1) Anaemia 12 (21 8) (30 5) Diarrhoea 8 (14 5) (6 8) Rash 8 (14 5) (1 7) Cough 7 (12 7) (6 8) Hypertension 7 (12 7) (8 5) Nausea 7 (12 7) (5 1) CMV test positive 6 (10 9) (1 7) Pruritus 6 (10 9) (1 7) Vomiting 6 (10 9) (0 0) Infusion-related reaction 5 (9 1) (0 0) Pneumonia 5 (9 1) (3 4) Urticaria 5 (9 1) (3 4) Increased blood creatinine 4 (7 3) (1 7) Bone pain 4 (7 3) (0 0) Decreased WBC count 4 (7 3) (3 4) Back pain 3 (5 5) (1 7) Bronchitis 3 (5 5) (1 7) Constipation 3 (5 5) (3 4) Dizziness 3 (5 5) (3 4) Dyspnoea 3 (5 5) (0 0) Fatigue 3 (5 5) (6 8) Febrile neutropenia 3 (5 5) (6 8) Headache 3 (5 5) (0 0) Nasopharyngitis 3 (5 5) (8 5) Decreased neutrophil count 3 (5 5) (6 8) Decreased platelet count 3 (5 5) (10 2) Pleural effusion 3 (5 5) (0 0) Urinary tract infection 3 (5 5) (0 0) Increased ALT 2 (3 6) (5 1) Asthenia 2 (3 6) (8 5) Decreased haemoglobin 2 (3 6) (5 1) Abdominal pain upper 0 (0 0) (5 1) Upper respiratory tract infection 0 (0 0) (5 1) AE, adverse event (regardless of causality, unless otherwise specified); CMV, Cytomegalovirus; WBC, White blood cell count; ALT, Alanine transaminase Page 3 of 6 Web Extra Material
5 Web Extra Table 4: AEs Occurring in 5% of Patients < 65 years of Age (N=109) (N=106) Patients 65 years old with at least 1 AE 107 (98 2) (87 7) Pyrexia 68 (62 4) (11 3) Neutropenia 58 (53 2) (49 1) Leukopenia 52 (47 7) (12 3) Thrombocytopenia 30 (27 5) (25 5) Chills 29 (26 6) (0 0) Anaemia 24 (22 0) (21 7) Lymphopenia 22 (20 2) (3 8) Infusion-related reaction 18 (16 5) (0 0) Urticaria 18 (16 5) (1 9) Rash 17 (15 6) (3 8) CMV test positive 14 (12 8) (0 0) Bronchitis 13 (11 9) (3 8) Nausea 13 (11 9) (9 4) Dermatitis allergic 12 (11 0) (3 8) Headache 11 (10 1) (3 8) Vomiting 9 (8 3) (2 8) Diarrhoea 8 (7 3) (6 6) Fatigue 8 (7 3) (4 7) Pruritus 8 (7 3) (2 8) Bronchospasm 7 (6 4) (0 0) Cough 6 (5 5) (3 8) Cytokine release syndrome 6 (5 5) (0 0) Hyperthermia 6 (5 5) (0 0) Pharyngitis 6 (5 5) (4 7) Pneumonia 6 (5 5) (0 9) AE, adverse event (regardless of causality, unless otherwise specified); CMV, Cytomegalovirus Page 4 of 6 Web Extra Material
6 Web Extra Table 5: AEs Occurring in 5% of Male Patients (N=105) (N=106) Male patients with at least 1 AE 103 (98 1) (89 6) Pyrexia 61 (58 1) (8 5) Neutropenia 51 (48 6) (46 2) Leukopenia 40 (38 1) (14 2) Thrombocytopenia 32 (30 5) (27 4) Chills 30 (28 6) (1 9) Anaemia 15 (14 3) (22 6) Lymphopenia 14 (13 3) (2 8) Rash 12 (11 4) (2 8) Urticaria 12 (11 4) (1 9) Bronchitis 11 (10 5) (1 9) Infusion-related reaction 11 (10 5) (0 0) Nausea 10 (9 5) (7 5) CMV DNA test positive 9 (8 6) (0 9) Diarrhoea 9 (8 6) (3 8) Fatigue 9 (8 6) (5 7) Vomiting 8 (7 6) (1 9) Cough 7 (6 7) (4 7) Headache 7 (6 7) (1 9) Dermatitis allergic 6 (5 7) (0 9) Hypertension 6 (5 7) (4 7) Pneumonia 6 (5 7) (1 9) Decreased platelet count 3 (2 9) (5 7) AE, adverse event (regardless of causality, unless otherwise specified); CMV, Cytomegalovirus Page 5 of 6 Web Extra Material
7 Web Extra Table 6: AEs Occurring in 5% of Female Patients (N=59) (N=59) Female patients with at least 1 AE 58 (98 3) (91 5) Pyrexia 37 (62 7) (10 2) Neutropenia 35 (59 3) (59 3) Leukopenia 34 (57 6) (18 6) Anaemia 21 (35 6) (28 8) Lymphopenia 21 (35 6) (6 8) Chills 19 (32 2) (0 0) Thrombocytopenia 15 (25 4) (27 1) Rash 13 (22 0) (3 4) Infusion-related reaction 12 (20 3) (0 0) Urticaria 11 (18 6) (3 4) CMV test positive 11 (18 6) (0 0) Nausea 10 (16 9) (8 5) Pruritus 9 (15 3) (3 4) Dermatitis allergic 8 (13 6) (5 1) Bronchospasm 7 (11 9) (0 0) Diarrhoea 7 (11 9) (11 9) Headache 7 (11 9) (3 4) Vomiting 7 (11 9) (1 7) Bone pain 6 (10 2) (0 0) Cough 6 (10 2) (5 1) Hypertension 6 (10 2) (1 7) Bronchitis 5 (8 5) (5 1) Pneumonia 5 (8 5) (1 7) Cholecystitis chronic 4 (6 8) (1 7) Drug eruption 4 (6 8) (0 0) Stomatitis 4 (6 8) (0 0) Asthenia 3 (5 1) (3 4) CMV infection 3 (5 1) (0 0) Decreased haemoglobin 3 (5 1) (5 1) Decreased platelet count 3 (5 1) (6 8) Pollakiuria 3 (5 1) (0 0) Pruritus allergic 3 (5 1) (0 0) Respiratory tract infection viral 3 (5 1) (1 7) Decreased WBC count 3 (5 1) (3 4) Fatigue 2 (3 4) (5 1) Nasopharyngitis 2 (3 4) (6 8) Decreased neutrophil count 2 (3 4) (5 1) Febrile neutropenia 2 (3 4) (6 8) Respiratory tract infection 1 (1 7) (5 1) Herpes zoster 0 (0 0) (5 1) Peripheral sensory neuropathy 0 (0 0) (5 1) AE, adverse event (regardless of causality, unless otherwise specified); CMV, Cytomegalovirus; WBC, White blood cell Page 6 of 6 Web Extra Material
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Poordad F, Lawitz E, Kowdley KV, et al. Exploratory study of
Study No: Title : Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Statistical Methods:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
January 2011 NCIC CTG MA.20 (RTOG Endorsed) -1. Opened: December 14, 1999 Closed: February 2, 2007
January 2011 NCIC CTG MA.20 (RTOG Endorsed) -1 NCIC CTG MA.20 (RTOG Endorsed) Protocol Status: Opened: December 14, 1999 Closed: February 2, 2007 Title: A Phase III Study of Regional Radiation Therapy
CASE REPORT FORM (April 2012)
CASE REPORT FORM (April 2012) Surveillance of Paediatric Dengue National Paediatric Hospital, Phnom Penh Kingdom of Cambodia Study contact: I am confident that the information supplied in this case record
NSABP PROTOCOL B-39 RTOG PROTOCOL 0413
NSABP PROTOCOL B-39 RTOG PROTOCOL 0413 A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
The dher2 immunotherapeutic consists of recombinant dher2 protein combined with the GSK s proprietary immunostimulant AS15.
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2- overexpressing tumors Steven A. Limentani, Mario Campone, Thierry
East West Acupuncture & Wellness Center, Inc. Patient Intake Form
East West Acupuncture & Wellness Center, Inc. Patient Intake Form Date: / / How did you hear about us? ( )Ad ( ) Healthcare Referral ( ) Friend/Family Whom may we thank for the referral? Name DOB / / Age
What are you seeking treatment for? Have you ever had acupuncture before? If so, for what condition?
Name Date What are you seeking treatment for? Have you ever had acupuncture before? If so, for what condition? Do you bruise or bleed easily? q Yes q No Pain l r b = left, right, both past current q q
S0819 Phase III. Coordinating Group: SWOG
S0819 Phase III Coordinating Group: SWOG A Randomized Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/ with or without Concurrent Cetuximab in Patients with Advanced Non-Small
Drug Analysis Print Drug name: RIMONABANT
Jump to first report page Report type: Spontaneous Total number of reactions*: 2123 Total number of ADR reports: 720 Total number of fatal ADR reports: 5 Products included in this print - products (PBGs):
ADULT INTAKE FORM (13 and older) Name Date of First Visit Address City State Zip Code Telephone (home) (work) (cell) Is it ok to leave a message?
ADULT INTAKE FORM (13 and older) Name Date of First Visit Address City State Zip Code Telephone (home) (work) (cell) Is it ok to leave a message? Age Date of Birth Gender Identity Relationship: Single
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase 1/2 study
Published Ahead of Print on May 17, 2018, as doi:10.3324/haematol.2017.171249. Copyright 2018 Ferrata Storti Foundation. Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia
APRIL 11-14, 2018 SWOG LYMPHOMA
LYMPHOMA COMMITTEE APRIL 11-14, 2018 SWOG LYMPHOMA 1 CONTENTS S0816 Phase II... 6 S1608 Phase II... 30 EAY131 Master Protocol / Phase II... 32 APRIL 11-14, 2018 SWOG LYMPHOMA 2 Patient Registrations to
Non Prolotherapy Patient Intake Form
Non Prolotherapy Patient Intake Form Scottsdale Pain Rehabilitation & Wellness Fred G. Arnold, N.M.D. 7595 East McDonald Drive, Suite 100 Scottsdale, AZ 85250 (O) 602 292-2978 Fax: 480-219- 8132 www.prolotherapyphoenix.com
Divine Medicine NW Greenbrier Parkway, Suite 100 Beaverton, Oregon P F
Divine Medicine 15455 NW Greenbrier Parkway, Suite 100 Beaverton, Oregon 97006 P 503.466.2722 F 503.644.1293 Patient Demographic Information: Patient Name Street Address Last Name First Name Middle Initial
What is your stress level(1- none 10- very stressful) Occupational Personal
Patient Information form (Please Print) Name: Date of Birth: How do you identify? Male Female Two-spirit Transgendered Intersexed Are you indigenous? If so, please identify Address Postal Code: Phone:
American Society of Hematology Annual Meeting December 10, 2017
Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM) Adam D. Cohen, Alfred
Philip J Cimo DDS PA 650 West Bough Lane Ste #160 Houston TX
Philip J Cimo DDS PA 650 West Bough Lane Ste #160 Houston TX 770024 O: (713)464-1887 F: (713)461-0605 PATIENT INFORMATION Date: / / Patient Name: First MI Last Address: Date of Birth: Social Security #:
Allogeneic Bone Marrow Transplant Crossword Puzzle on Discharge Education
Allogeneic Bone Marrow Transplant Crossword Puzzle on Discharge Education Across 1. If you have, it is important to inform their school that you must be notified of communicable diseases like measles,
Dynamics of a Cytokine Storm Robert Stengel* MAE, Princeton University 2012"
Dynamics of a Cytokine Storm Robert Stengel* MAE, Princeton University 2012 Basic Adaptive Immune Response to Infection Cytokine Signaling and Inflammation TGN1412 Phase I Clinical Trial Modeling the Response
Holly Zapf, ND -- Whole Family Health Clinic
Holly Zapf, ND -- Whole Family Health Clinic 2928 SE Hawthorne, Suite 106, Portland, OR 97214 phone: 503-460-0630 fax: 503-231-4003 wholefamily97214@gmail.com Name: Date: Address: City: State: Zip Code:
Effects of AG-348, a pyruvate kinase activator, in patients with pyruvate kinase deficiency: Updated results from the DRIVE PK study
S451 Effects of AG-348, a pyruvate kinase activator, in patients with pyruvate kinase deficiency: Updated results from the DRIVE PK study Rachael F Grace* 1, D Mark Layton 2, Frédéric Galactéros 3, Christian
Yen Chiropractic, LLC Personal Injury Patient Intake Form Page 1
GENERAL INFORMATION: TODAY'S DATE: YEN CHIROPRACTIC DR. DANIEL D. YEN, D.C. 4528 W CRAIG RD, SUITE 190 NORTH LAS VEGAS, NV 89032 PATIENT NAME: SOCIAL SECURITY #: ADDRESS: CITY: STATE: ZIP: EMAIL: SEX:
(PLEASE CIRCLE YES ANSWERS ONLY)
(PLEASE CIRCLE YES ANSWERS ONLY) Childhood Illnesses Scarlet Fever Y N Diphtheria Y N Rheumatic fever Y N Mumps Y N Measles Y N German Measles Y N Hospitalizations and Surgery What hospitalizations or
Anatomy & Physiology Curriculum Map Date Content/Topics Objectives Activities/Assessments Aug. 7th- 21st
Anatomy & Physiology Curriculum Map 2012-13 Date Content/Topics Objectives Activities/Assessments Aug. 7th- 21st Chapter 1 Body Regions/Cavities Directional Terms Homeostasis System Basics with introduction
Online supplement. Absolute Value of Lung Function (FEV 1 or FVC) Explains the Sex Difference in. Breathlessness in the General Population
Online supplement Absolute Value of Lung Function (FEV 1 or FVC) Explains the Sex Difference in Breathlessness in the General Population Table S1. Comparison between patients who were excluded or included
Autologous Bone Marrow Transplant Crossword Puzzle on Discharge Education. Adult Bone Marrow Transplant Autologous Bone Marrow Transplant Puzzle 1
Autologous Bone Marrow Transplant Crossword Puzzle on Discharge Education 1 Across 1. You will not be able to for at least three months following your transplant. This period may be shorter for patients
Patient Intake Form. Name Date of birth Age Sex: Male Female
Patient Intake Form Today s date: Name Date of birth Age Sex: Male Female Health Concerns: Please list your main health concerns in order of importance. 1. Describe your primary concern When did it start?
H E A LT H H I S T O RY
H E A LT H H I S T O RY Name: : List All Current Health Problems: List Any Other Doctors Seen, Treatments And Results Obtained: Your Current Physician(s)/Therapist(s): List All Surgeries And Their s: List
Supplemental Table 1 All Adverse Events Reported with Tolvaptan in North American & Japanese Subjects
Supplemental Table 1 All Adverse Events Reported with Tolvaptan in North American & Japanese Subjects Number of Subjects Reporting AE (%) MedDRA Adverse Event Term 156-05-002 or TEMPO 15/15 mg/day N=17
12/1/17 OUTLINE KEY POINTS ELEMENTS WITH UNSTABLE NUCLEI Radioisotopes and Nuclear Reactions 16.2 Biological Effects of Nuclear Radiation
OUTLINE 16.1 Radioisotopes and Nuclear Reactions 16.2 Biological Effects of Nuclear Radiation PET scan X-ray technology CT scan 2009 W.H. Freeman KEY POINTS Radioactivity is the consequence of an unstable
Unit code: K/503/1682 QCF level: 4 Credit value: 15
Unit 10: Anatomy and Physiology Unit code: K/503/1682 QCF level: 4 Credit value: 15 Aim This unit aims to develop learner understanding of physical support and movement in animals, body transport systems,
Chronic Granulomatous Disease Medical Management
Chronic Granulomatous Disease Medical Management N I C H O L A S H A R T O G, M D D i r e c t o r o f P e d i a t r i c / A d u l t P r i m a r y I m m u n o d e f i c i e n c y C l i n i c A s s i s t
SONG OF NATURAL MEDICINE Dr. Crystal Song, NMD
Patient Intake Form DATE: Patient Name: List in Order of importance what your problems are: 1) 2) 3) DOB: Last time you had wellness checkup and with what physician: Family History Father Mother Siblings
HEALTH HISTORY FORM. Patient Name: Birth Date: / / Supportive relationship(s)? Yes No Spiritual Practice? Yes No If yes,
HEALTH HISTORY FORM PERSONAL INFORMATION: Today s Date: Patient Name: Birth Date: / / Supportive relationship(s)? Yes No Spiritual Practice? Yes No If yes, Any pets/farm animals? Yes No If yes, Have you
Adult Intake. (Please print clearly) Name Date. Address. Address. Home Telephone Number. Emergency contact: Name
Adult Intake (Please print clearly) Name Date Date of birth (M/D/Y) Sex M F Address E-mail Address Home Telephone Number Work _ May we leave messages relating to your visits? Y / N Which Phone Number?
License flow for use of nuclear material.
Figure 2.1. License flow for use of nuclear material. Figure 2.2. License flow for the manufacturing business. 1 Figure 2.3. Major legislations and guides governing the safety regulation of fabrication
NEW PATIENT INTAKE. Name: Date: Address: Preferred Phone: ( ) Alternate Phone:( ) Leaving Voice Message OK: Y N Preferred method of contact:
NEW PATIENT INTAKE Patient Information: Name: Date: Address: Preferred Phone: ( ) Alternate Phone:( ) Leaving Voice Message OK: Y N Preferred method of contact: E-mail address: Age: Date of Birth: / /
CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus
CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais Sanusi Datuk
Broken Arrow Public Schools Physiology Objectives
1 st six weeks 1 Define anatomy and physiology. 2 Compare and contrast levels of structural organization. 3 Identify necessary life functions and essential needs and how they are related to homeostasis.
Erythrocyte. Erythrocytes (unstained) thin membrane. refractive index varies by hemoglobin content; ghost cells seen with low hemoglobin
Erythrocyte SYNONYMS RBC, red cell VITAL STATISTICS size... diameter 7-8 μm shape... round to slightly oval biconcave disk, crenated in hypertonic specimens with irregular edges and surfaces, spherical
January NCCTG Protocol No: N0628 Opened: November 27, 2007 CALGB Protocol No: ECOG Protocol No: R0617
January 2011 0617-1 RTOG Protocol No: 0617 Protocol Status: NCCTG Protocol No: N0628 Opened: November 27, 2007 CALGB Protocol No: 30609 ECOG Protocol No: R0617 Title: A Randomized Phase III Comparison
Address: City: State: Zip: Age: Birth Date: Marital Status: M S W D No. of Children. Your Employer: Occupation: Years on Job:
C O N F I D E N T I A L PAT I E N T I N F O R M AT I O N The following information is needed in order to better serve you. Please complete all questions. If you need help, please ask the receptionist.
Date of Birth Gender. List, in order of importance, your goals for working with your physician:
List, in order of importance, your goals for working with your physician: 1. 2. 3. 4. 5. Please list your allergies and what happens when you are exposed to the allergen: Drug Allergies: Food Allergies:
Premier Pain Consultants
Premier Pain Consultants Advanced Solutions For Pain Relief Name: DOB: Who is your primary care physician/family doctor? What is the major reason you are coming to see the doctor (chief complaint): How
Integrative Medicine and Holistic Wellness Center 677 West Main Street Hyannis, MA 02601
Integrative Medicine and Holistic Wellness Center 677 West Main Street Hyannis, MA 02601 Informed Consent for Health Consultation: I herby authorize my practitioner to advise the use of the following therapies.
Machine Learning. Neural Networks. Le Song. CSE6740/CS7641/ISYE6740, Fall Lecture 7, September 11, 2012 Based on slides from Eric Xing, CMU
Machine Learning CSE6740/CS7641/ISYE6740, Fall 2012 Neural Networks Le Song Lecture 7, September 11, 2012 Based on slides from Eric Xing, CMU Reading: Chap. 5 CB Learning highly non-linear functions f:
COOK ISLANDS TE MARAE ORA
COOK ISLANDS MINISTRY OF HEALTH TE MARAE ORA ANNUAL STATISTICAL TABLES HEALTH STATISTICAL TABLES 2008-2010 MEDICAL RECORDS UNIT Rarotonga Hospital It should be noted that information contained in this
Adaptive Play and Wellness. Miela Gruber Cooley ND Registration Form (Please Print)
KIDSPACE Adaptive Play and Wellness 469 Buckland Road South Windsor, CT 06074 phone (860) 432-9923 fax (860) 432-7553 Miela Gruber Cooley ND Registration Form (Please Print) Today s Date: PCP: Patient
Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from
Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Islands, China: implication for transmission across the ocean Yongfeng Fu 1, Shibo Li 1, Zhao Zhang 1, Suqin Man, Xueping
Family History. Patient Name: DOB: List in Order of importance what your health concerns are: 1) 2) 3) 4) 5)
Naturopathic Heart Institute of Tucson, LLC June E. Stevens NMD Southwest Integrative Healthcare 2802 N. Alvernon Way, Suite 200 Tucson, AZ 85712 (520) 326-0850 (520) 326-0849 Patient Name: DOB: List in
(Work address): How did you hear about our clinic? Has any other family member already been a patient at the clinic?
Name: Date: Address: City: State: Zip Code: Telephone # (home): (work): E-mail address: Age: Date of Birth: Gender: female male Education: Married: Separated: Divorced: Widowed: Single:_ Partnership:_
ADULT INTAKE. Name: Date: Address: City: Prov: PC: Telephone (home): (work): Age: Date of Birth: Gender: Female / Male
ADULT INTAKE Name: Date: Address: City: Prov: PC: Telephone (home): (work): Age: Date of Birth: Gender: Female / Male Married: Separated: Divorced: Widowed: Single: Partnership: Live with: Spouse: Partner:
Portland Dental and Naturopathic Clinic
Portland Dental and Naturopathic Clinic Adult Intake Form Name Date of First Visit Address City State Zip Code Telephone # (home) (work) Cell Email address Age Date of Birth Gender: female male Education
Arizona Integrative Medical Solutions 4657 S. Lakeshore Dr, Ste #1 Tempe, AZ
Arizona Integrative Medical Solutions 4657 S. Lakeshore Dr, Ste #1 Tempe, AZ 85282 480-284- 8155 Female Health History Patient Name: Date: DOB: Age: Street Address: City: State: Zip: Home phone: Work Phone:
Bayeasian Logistic Regression with application to Assessing Drug Safety Issues
Bayeasian Logistic Regression with application to Assessing Drug Safety Issues A PROJECT SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA DULUTH BY Xuran Yan IN PARTIAL FULFILLMENT
Drug Analysis Print Drug name: CLOZAPINE
Jump to first report page Report type: Spontaneous Total number of reactions*: 9866 Total number of ADR reports: 3259 Total number of fatal ADR reports: 515 Products included in this print - products (PBGs):
Charlotte, NC (980) Roanoke, VA (540)
New Patient Information NAME: SEX: / / AGE: (Last) (First) ADDRESS: CITY: STATE: ZIP: HOME PHONE:( ) CELL PHONE: ( ) WORK PHONE: ( ) EMAIL ADDRESS: SSN: Would you like to receive our email newsletter?
Hazard Communication & Globally Harmonized System (GHS)
Hazard Communication & Globally Harmonized System (GHS) Introductions Construction Safety Compliance Develop a Common Understanding of: 1. What do You Need to KNOW 2. What do You Need to DO Miscommunicated
Modeling and reasoning with uncertainty
CS 2710 Foundations of AI Lecture 18 Modeling and reasoning with uncertainty Milos Hauskrecht milos@cs.pitt.edu 5329 Sennott Square KB systems. Medical example. We want to build a KB system for the diagnosis
Sioux Falls School District Anatomy and Physiology Holes Anatomy and Physiology Authors: Shier, Butler, and Lewis Glencoe/ McGraw hill
Sioux Falls School District Anatomy and Physiology Holes Anatomy and Physiology Authors: Shier, Butler, and Lewis Glencoe/ McGraw hill Semester 1 Chapter 1: Introduction to Human Anatomy and Physiology
GPS * Safety Summary for Hydrochloric Acid
GPS * Safety Summary for Hydrochloric Acid Select a Topic: Names Product Overview Manufacture of Product Product Description Product Uses Exposure Potential Health Information Environmental Information
Drug Dosage Forms Dr. Stephanie Farrell
Drug Dosage Forms Dr. Stephanie Farrell Introduction Lozenges are solid drug dosage forms containing a drug along with flavoring and sweetening agents. Lozenges are formulated to be harder than ordinary
Tortora Funke Case Biology Quiz
Tortora Funke Case Biology Quiz Free PDF ebook Download: Tortora Funke Case Biology Quiz Download or Read Online ebook tortora funke case biology quiz in PDF Format From The Best User Guide Database This
NCCTG Status Report for Study N May 2010
Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for dvanced Small Bowel denocarcinoma Purpose of - Primary Goal Study: 1) To assess the
A2.19. Supplementary Materials for Appendix 2
A2.19 Supplementary Materials for Appendix 2 A2.20 Parameter Ref. Low Ref. High 12 Month 6 Month 3 Month Rabbit ID# B-51 B-71 B-51 B-52 B-53 B-54 B-55 B-56 B-57 B-58 B-59 B-60 B-61 B-62 B-63 B-64 B-65
By: Marek Tuliszka D.Sc. Department of Biophysics Poznań University of Medical Sciences, Poland
By: Marek Tuliszka D.Sc. Department of Biophysics Poznań University of Medical Sciences, Poland TEMPERATURE REFLECTS THE THERMAL ENERGY CONTENT OF A SYSTEM (THE INTERNAL ENERGY) UNITS OF HEAT, ENERGY AND
CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus
CHAPTER 3 Editors: Mr Mohamed Ezani Md. Taib Dato Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais Sanusi Datuk Dr Aizai Azan Abdul Rahim Dr Ashari
OXAPROZIN Bioanalytical method development and Validation using HPLC
OXAPROZIN Bioanalytical method development and Validation using HPLC 4.1 DRUG PROFILE Oxaprozin Oxaprozin is a non-narcotic and non-steroidal anti-inflammatory drug (NSAID) used to relieve the inflammation,
J. Iran. Chem. Soc., Vol. 5, No. 3, September 2008, pp JOURNAL OF THE Iranian Chemical Society
J. Iran. Chem. Soc., Vol. 5, No. 3, September 2008, pp. 498-505. JOURNAL OF THE Iranian Chemical Society Theoretical Studies of 1-(4-Substituted-5-hydroxymethyl-tetrahydro-furan-2- ylmethyl)-5-methyl-1h-pyrimidine-2,4-dione
DR.CRISTINA COLOMA, ND 2888 GARDNER COURT ABBOTSFORD, BC V2T 5H9 Phone/Fax (604)
DR.CRISTINA COLOMA, ND 2888 GARDNER COURT ABBOTSFORD, BC V2T 5H9 Phone/Fax (604) 556-4596 E-mail: abbynaturopath@gmail.com Name: Date: Address: City: Province/State: Zip/Postal Code: Telephone # (home):
GPS* Safety Summary for Hydrochloric Acid
GPS* Safety Summary for Hydrochloric Acid Select a Topic: Names Product Overview Manufacture of Product Product Description Product Uses Exposure Potential Health Information Environmental Information
Dr. Kevin Passero, N.D Lubrano Drive, Suite L 15, Annapolis, MD New Hampshire Ave Suite B4 NW Washington DC 20036
Dr. Kevin Passero, N.D. 443-433-5540 130 Lubrano Drive, Suite L 15, Annapolis, MD 21401 1330 New Hampshire Ave Suite B4 NW Washington DC 20036 Health History Form Name: Date: Address: City: State: Zip
c u l t i v a t e w e l l n e s s
Patient Information Name Age Date of birth Sex: Male Female Amy Bader, ND n atu r o p a t h i c d o c t o r Date Address City State Zip Telephone (Home) (Work) (Cell) Email Emergency Contact Relationship
NCCTG Status Report for Study N May 2010
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI-571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Purpose of - Objectives Study: 1) Study 1: To identify the MTD of imatinib
G-CSF treatment of chemotherapy induced. neutropenia - Online supplement
G-CSF treatment of chemotherapy induced neutropenia - Online supplement Eliezer Shochat and Vered Rom-Kedar Weizmann Institute of Science May 31, 2008 1 The online supplement begins with introducing the
Dr. Roxie Strand, NMD
Dr. Roxie Strand, NMD Name: Date: Address: City: State: Zip Code: Telephone # home: work: cell: E-mail address: Age: Date of Birth: Gender: female male Education: Married: Separated: Divorced: Widowed:
Naturopathic Intake Paperwork
3500 Kensington Ave Suite B- 2 Richmond, VA 23221 T/F 804-977- 2634 Naturopathic Intake Paperwork 1) What led you to choosing this clinic? 2) What do you know about us and how we work? 3) What three expectations
The following information is needed in order to better serve you. Please complete all questions.
C O N F I D E N T I A L PAT I E N T I N F O R M AT I O N The following information is needed in order to better serve you. Please complete all questions. If you need help, please ask the receptionist.
1. Why Dissect. Why are frogs a good model to use when studying the digestive system (as well as other systems)?
Name: Date: Period: Frog Dissection Virtual Lab Use the frog Dissection link that follows to answer the questions. http://www.mhhe.com/biosci/genbio/virtual_labs/bl_16/bl_16.html Introduction 1. Why Dissect.
observed value = true value + error
Measurement, Measurement Errors, and Measuring Measurement Errors in Clinical Medicine 1. Background In many circumstances clinical decisions will be guided by measurements of some kind. Common examples
History of Present Illness
Dr. Paul D. Jantzi Brazos Valley Allergy & Asthma Clinics (979) 836-5582 or (800) 362-9633 History of Present Illness Office Visit Date: Time: Location: Patient Name: Primary Physician (PCP): Date of Birth:
INTAKE FORM ADULT. Contact Information. Date
INTAKE FORM ADULT Basic Information Dr Aoife M Earls, BSc, MSc Naturopathic Doctor Suite 212, 345 Lakeshore Rd E, Oakville, ON L6H 6K7 1.905.849.6730 draoife.com Date Name Date of Birth YYYY-MM-DD Sex
K a Acid Dissociation Constant Minneapolis Community and Technical College Principles of Chemistry II, C1152 v.9.13
K a Acid Dissociation Constant Minneapolis Community and Technical College Principles of Chemistry II, C1152 v.9.13 I. Introduction Acetic Acid Monoprotic acetic acid, CH 3 COOH is sometimes written as
MATHEMATICAL MODEL FOR CO-INFECTION OF PNEUMONIA AND TYPHOID FEVER DISEASE WITH OPTIMAL CONTROL
MATHEMATICAL MODEL FOR CO-IFECTIO OF PEUMOIA AD TYPHOID FEVER DISEASE WITH OPTIMAL COTROL Getachew Teshome Tilahun Ph.D Doctor of Philosophy Mathematics (Computational option) 2017 MATHEMATICAL MODEL FOR
Family members living at home with the patient: Patient s school: Emergency contact: Relationship: Phone:
Nature Cures Naturopathic Clinic Dr. Cathy Picard, Naturopathic Physician 250 Eddie Dowling Hwy., N.Smithfield, RI 02896 Phone: 401-597-0477 Fax: 401-597-0959 www.drcathypicard.com ADOLESCENT INTAKE FORM
Perplexing Observations. Today: Thinking About Darwinian Evolution. We owe much of our understanding of EVOLUTION to CHARLES DARWIN.
Today: Thinking About Darwinian Evolution Part 1: Darwin s Theory Perplexing Observations Mystery of the Black Death?? What is evolution?? And what is this finch doing?!? We owe much of our understanding
January NCCTG Protocol No: N0927 Opened: September 3, 2009
January 2011 0915-1 RTOG Protocol No: 0915 Protocol Status: NCCTG Protocol No: N0927 Opened: September 3, 2009 Title: A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT)
Clinical performance of Swelab Lumi 5-part hematology analyzer
Clinical performance of Swelab Lumi -part hematology analyzer A complete blood count (CBC) is frequently requested by physicians to obtain information about a patient s blood status, and tests are routinely
HTHS 1110 / Biomedical Core Module 1
HTHS 1110 / Biomedical Core Module 1 Body Plan & Organization Homeostasis Disease: A Disruption in Homeostasis Measurement Systems and Calculations Used for the Human Body Body Plan & Organization Anatomy
Nuclear Physics and Astrophysics
Nuclear Physics and Astrophysics PHY-302 Dr. E. Rizvi Lecture 24 Medical Imaging Effects of Radiation We now know what radiation is But what does it mean for our bodies? Radioactivity is quantified in
A NEW PANAGGLUTININ IN A TRANSFUSION-DEPENDENT PATIENT A Case Study by Jim Perkins, M.D. ( 2009)
A NEW PANAGGLUTININ IN A TRANSFUSION-DEPENDENT PATIENT A Case Study by Jim Perkins, M.D. ( 2009) History: J.N. was a 70 year-old male diagnosed with B-cell chronic lymphocytic leukemia (CLL) in 1998 who
Statistical tables are attached Two Hours UNIVERSITY OF MANCHESTER. May 2007 Final Draft
Statistical tables are attached wo Hours UNIVERSIY OF MNHESER Ma 7 Final Draft Medical Statistics M377 Electronic calculators ma be used provided that the cannot store tet nswer LL si questions in SEION
Natural Healing Family Medicine
Adult Intake Form Last Name: First Name: Date: Address: City: State Zip Telephone (Home): Telephone (Work): Email Address: Age: Date of Birth: Gender: Married: Separated: Divorced: Widowed: Single: Partnership:
Toxic Algae and Cyanobacteria in Recreational Waters. Rang Cho Miriam Moritz
Toxic Algae and Cyanobacteria in Recreational Waters Rang Cho Miriam Moritz Algae Large, diverse group of eukaryotic organisms Contain chlorophyll and/or other pigments green, brown or red colour Perform
Chemical Kinetics: Reaction Rates Minneapolis Community and Technical College C1152 v.5.10
Chemical Kinetics: Reaction Rates Minneapolis Community and Technical College C5 v.5.0 I. Introduction The Reactions Question #: Will a given chemical reaction occur? This question is very important especially
Passaic County Technical Institute. Wayne, NJ. Anatomy and Physiology II Curriculum. August 2015
Passaic County Technical Institute Wayne, NJ Anatomy and Physiology II Curriculum August 2015 Anatomy and Physiology II Curriculum August 2015 I. Course Description Anatomy and Physiology II is a full
Communicable Disease Report July 2018
Licking County Health Department Communicable Disease Report July This report contains information regarding suspected, probable, and confirmed cases of the diseases listed and are subject to change Ohio
EXTREME WEATHER (HOT/COLD/STORMS) POLICY
EXTREME WEATHER (HOT/COLD/STORMS) POLICY Participation in extreme weather conditions is a risk that can be avoided to ensure the safety of AU Sport members. Remember not only to take players into account